Central venous catheter (CVC)-related infections in neutropenic patients - Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Annals of Hematology

Volumn 82, Issue SUPPL. 2, 2003, Pages

  Fätkenheuer, Gerd ^a   Buchheidt, Dieter ^b   Cornely, Oliver A ^a   Fuhr, Hans Georg ^c   Karthaus, Meinolf ^d   Kisro, Jens ^e   Leithäuser, Malte ^f   Salwender, Hans ^g   Südhoff, Thomas ^h   Szelényi, Hubert ⁱ   Weissinger, Florian ^j  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c DR HORST SCHMIDT KLINIKEN   (Germany)

^d EVANGELISCHES KRANKENHAUS   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f UNIVERSITY OF ROSTOCK   (Germany)

^g ASKLEPIOS KLINIK ALTONA   (Germany)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ FREIE UNIVERSITÄT BERLIN   (Germany)

^j UNIVERSITY OF WÜRZBURG   (Germany)

more..

Author keywords

Blood culture; Catheter related infection; Differential time to positively; Neutropenia; Staphylococcus aureus

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CASPOFUNGIN; CHLORHEXIDINE; DALFOPRISTIN PLUS QUINUPRISTIN; FLUCONAZOLE; GENTAMICIN; ITRACONAZOLE; LINEZOLID; METICILLIN; MINOCYCLINE; OXACILLIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; SULFADIAZINE SILVER; VANCOMYCIN; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BLOOD CULTURE; CANDIDA; CANDIDIASIS; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; GERMANY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION PREVENTION; INFECTION RISK; MATERIAL COATING; MEDICAL SOCIETY; MICROBIOLOGICAL EXAMINATION; NEUTROPENIA; NONHUMAN; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0142125781     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0769-z     Document Type: Review

References (70)

1. Dobbins BM, Kite P, Kindon A, McMahon MJ, Wilcox MH (2002) DNA fingerprinting analysis of coagulase negative staphylococci implicated in catheter related bloodstream infections. J Clin Pathol 55:824-828
2. Kristinsson KG (1997) Diagnosis of Catheter-Related Infections. In: Seifert H, Jansen B, Farr BM (eds) Catheter-Related Infections. Marcel Dekker, New York, pp 31-57
3. Greene JN (1996) Catheter-related complications of cancer therapy. Infect Dis Clin North Am 10:255-295
4. Engelhard D, Elishoov H, Strauss N, Naparstek E, Nagler A, Simhon A, Raveh D, Slavin S, Or R (1996) Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study. Transplantation. 61:430-434
5. Anonym (1996) Guideline for prevention of intravascular device-related infections. Part II. Recommendations for the prevention of nosocomial intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Am J Infect Control 24:277-293
6. Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B (1998) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767-773
7. Raad I, Davis S, Becker M, Hohn D, Houston D, Umphrey J, Bodey GP (1993) Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 153:1791-1796
8. Karthaus M, Doellmann T, Klimasch T, Krauter J, Heil G, Ganser A (2002) Central venous catheter infections in patients with acute leukemia. Chemotherapy 48:154-157
9. Elishoov H, Or R, Strauss N, Engelhard D (1998) Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine (Baltimore) 77:83-101
10. Nouwen JL, Wielenga JJ, van Overhagen H, Lameris JS, Kluytmans JA, Behrendt MD, Hop WC, Verbrugh HA, de Marie S (1999) Hickman catheter-related infections in neutropenic patients: insertion in the operating theater versus insertion in the radiology suite. J Clin Oncol 17:1304
11. Howell PB, Walters PE, Donowitz GR, Farr BM (1995) Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer 75:1367-1375
12. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, Valles J (2000) Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162:1027-1030
13. Renaud B, Brun-Buisson C (2001) Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163:1584-1590
14. Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO (1984) Hickman catheter infections in patients with malignancies. Medicine 63:189-200
15. Hampton AA, Sherertz RJ (1988) Vascular-access infections in hospitalized patients. Surg Clin North Am 68:57-71
16. Moro ML, Vigano EF, Cozzi Lepri A (1994) Risk factors for central venous catheter-related infections in surgical and intensive care units. The Central Venous Catheter-Related Infections Study Group [published erratum appears in Infect Control Hosp Epidemiol 1994 Aug; 15(8):508-9]. Infect Control Hosp Epidemiol 15:253-264
17. Snydman DR, Murray SA, Kornfeld SJ, Majka JA, Ellis CA (1982) Total parenteral nutrition-related infections. Prospective epidemiologic study using semiquantitative methods. Am J Med 73:695-699
18. Goetz AM, Wagener MM, Miller JM, Muder RR (1998) Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 19:842-845
19. Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK (2000) Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 117:178-183
20. Pemberton LB, Lyman B, Lander V, Covinsky J (1986) Sepsis from triple- vs single-lumen catheters during total parenteral nutrition in surgical or critically ill patients. Arch Surg 121:591-594
21. Yeung C, May J, Hughes R (1988) Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol 9:154-158
22. Farkas JC, Liu N, Bleriot JP, Chevret S, Goldstein FW, Carlet J (1992) Single- versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med 93:277-282
23. Ma TY, Yoshinaka R, Banaag A, Johnson B, Davis S, Berman SM (1998) Total parenteral nutrition via multilumen catheters does not increase the risk of catheter-related sepsis: a randomized, prospective study. Clin Infect Dis 27:500-503
24. Raad I (1998) Intravascular-catheter-related infections. Lancet 351:893-898
25. Sherertz RJ, Carruth WA, Marosok RD, Espeland MA, Johnson RA, Solomon DD (1995) Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo. J Biomed Mater Res 29:635-645
26. Darouiche RO (1999) Prevention of vascular catheter-related infections [editorial]. Neth J Med 55:92-99
27. Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggemann A, Napolitano LM, Edwards LP, O'Connell FM, Puyana JC, Doern GV (1998) Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 158:81-87
28. Sherertz RJ, Raad, II, Belani A, Koo LC, Rand KH, Pickett DL, Straub SA, Fauerbach LL (1990) Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 28:76-82
29. Seifert H, Cornely O, Seggewiss K, Decker M, Stefanik D, Wisplinghoff H, Fatkenheuer G (2003) Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J Clin Microbiol 41:118-123
30. Link H, Böhme A, Cornely OA, Höffken K, Kellner O, Kern WV, Mahlberg R, Maschmeyer G, Nowrousian MR, Ostermann H, Ruhnke M, Sezer O, Schiel X, Wilhelm M, Auner HW (2003) Antimicrobial therapy of unexplained fever in neutropenic patients. Ann Hematol 82 (Suppl 2) DOI 10.1007/s00277-003-0764-4
31. Mermel LA, Farr BM, Sherertz RJ, Raad, II, O'Grady N, Harris JS, Craven DE (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32:1249-1272
32. Safdar N, Maki DG (2002) Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 30:2632-2635
33. Plum J, Sudkamp S, Grabensee B (1994) Results of ultrasound-assisted diagnosis of tunnel infections in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 23:99-104
34. Kite P, Dobbins BM, Wilcox MH, McMahon MJ (1999) Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal [see comments]. Lancet 354:1504-1507
35. Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S, Laplanche A, Brun-Buisson C, Tancrede C (1999) Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 354:1071-1077
36. Rijnders BJ, Verwaest C, Peetermans WE, Wilmer A, Vandecasteele S, Van Eldere J, Van Wijngaerden E (2001) Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients. Crit Care Med 29:1399-1403
37. Capdevila JA, Planes AM, Palomar M, Gasser I, Almirante B, Pahissa A, Crespo E, Martinez-Vazquez JM (1992) Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis 11:403-407
38. Fan ST, Teoh-Chan CH, Lau KF, Chu KW, Kwan AK, Wong KK (1988) Predictive value of surveillance skin and hub cultures in central venous catheters sepsis. J Hosp Infect 12:191-198
39. Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296:1305-1309
40. Darouiche RO, Raad, II, Heard SO, Thomby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G (1999) A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 340:1-8
41. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M (1987) Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 147:873-877
42. Rijnders BJ, Van Wijngaerden E, Peetermans WE (2002) Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence? Clin Infect Dis 35:1053-1058
43. Dugdale DC, Ramsey PG (1990) Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 89:137-141
44. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB (1997) Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 127:275-280
45. Benezra D, Kiehn TE, Gold JW, Brown AE, Turnbull AD, Armstrong D (1988) Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 85:495-498
46. Severien C, Nelson JD (1991) Frequency of infections associated with implanted systems vs cuffed, tunneled Silastic venous catheters in patients with acute leukemia. Am J Dis Child 145:1433-1438
47. Dompeling EC, Donnelly JP, Deresinski SC, Feld R, Lane-Allman EF, De Pauw BE (1996) Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin. Eur J Cancer 32A:1332-1339
48. Erjavec Z, de Vries-Hospers HG, Laseur M, Halie RM, Daenen S (2000) A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy. J Antimicrob Chemother 45:843-849
49. Raad, II, Sabbagh MF (1992) Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis 14:75-82
50. Farr BM (1997) Catheter-related Staphylococcus aureus infection. In: Seifert H, Jansen B, Farr BM (eds) Catheter-related infections. Marcel Dekker, New York, pp 59-78
51. Gaillard JL, Merlino R, Pajot N, Goulet O, Fauchere JL, Ricour C, Veron M (1990) Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Parenter Enteral Nutr 14:593-597
52. Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B, Flynn L, Hayes S, Strong S, Cruz J, Bowton DL, Hulgan T, Haponik EF (2000) Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 132:641-648
53. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D (2000) Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 355:1864-1868
54. Raad, II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP (1994) Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15:231-238
55. Randolph AG, Cook DJ, Gonzales CA, Pribble CG (1996) Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med 24:2053-2058
56. Fridkin SK, Pear SM, Hagman E, Skogman K, Bjorkholm M (1996) The role of understaffing in central venous catheter-associated infections. Infect Control Hosp Epidemiol 17:150-158
57. Mimoz O, Pieroni L, Lawrence C, Edouard A, Costa Y, Samii K, Brun-Buisson C (1996) Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 24:1818-1823
58. Maki DG, Ringer M, Alvarado CJ (1991) Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339-343
59. Little JR, Murray PR, Traynor PS, Spitznagel E (1999) A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination. Am J Med 107:119-125
60. Cook D, Randolph A, Kernerman P, Cupido C, King D, Soukup C, Brun-Buisson C (1997) Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 25:1417-1424
61. Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O (1997) Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer 5:485-488
62. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA (1995) Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 31:189-193
63. Miller MA, Dascal A, Portnoy J, Mendelson J (1996) Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17:811-813
64. Maki DG, Stolz SS, Wheeler S, Mermel LA (1994) A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 22:1729-1737
65. Bijma R, Girbes AR, Kleijer DJ, Zwaveling JH (1999) Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol 20:618-620
66. Raad I, Hanna HA, Awad A, Alrahwan A, Bivins C, Khan A, Richardson D, Umphrey JL, Whimbey E, Mansour G (2001) Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol 22:136-139
67. Maki DG, Botticelli JT, LeRoy ML, Thielke TS (1987) Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective. Jama 258:1777-1781
68. Mermel LA (2000) Prevention of intravascular catheter-related infections. Ann Intern Med 132:391-402
69. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD (1999) Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. Jama 281:261-267
70. Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP (1992) Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 11:675-682